Otsuka Pharmaceutical Submits New Drug Application to U.S. FDA for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults

Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI). Clinical studies have shown that centanafadine significantly reduces core symptoms of ADHD in ...
Medical News Today

Olanzapine oral tablets

Olanzapine (Zyprexa) is approved to treat schizophrenia in adults and children ages 13 years and older, manic and mixed episodes related to bipolar I disorder in adults and children ages 13 years and ...
The Financial

U.S. FDA approves Synjardy XR tablets for adults with type 2 diabetes

The FINANCIAL — The U.S. Food and Drug Administration (FDA) has approved Synjardy XR (empagliflozin and metformin hydrochloride extended-release) tablets for adults with type 2 diabetes. When used ...
The Financial

First-in-class type 2 diabetes treatment Glyxambi tablets for adults now available in U.S. pharmacies

The FINANCIAL — Glyxambi (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S ...

Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder

Tonix plans to initiate potential pivotal Phase 2 HORIZON study of TNX-102 SL in adults with major depressive disorder in mid ...

Zydus Lifesciences shares in focus on tentative USFDA approval for Empagliflozin, Linagliptin tablets

The company received tentative approval from USFDA for diabetes drug, which will be produce in Ahmedabad facility.